Related Experiment Video

Updated: May 15, 2026

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

[Development of antibody drugs targeting against HER2 for cancer therapy]

Qin Tang1, Qian Ding, Li Lin

  • 1Department of Biochemistry, School of Medicine, Zhejiang University, Hangzhou, China.

Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|January 5, 2013
PubMed

Insights

Targeted antibody therapies, including trastuzumab and pertuzumab, offer specific, low-side-effect treatments for HER2-overexpressing cancers. This review covers current anti-HER2 antibody treatments and future drug development trends.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Human epidermal growth factor receptor 2 (HER2) is a transmembrane glycoprotein implicated in tumorigenesis and metastasis.
  • HER2 overexpression is prevalent in breast, ovarian, gastric, lung, and prostate cancers.
  • Targeted antibody therapies offer advantages over conventional chemotherapy due to specificity and reduced side effects.

Purpose of the Study:

  • To review the current landscape of anti-HER2 antibody monotherapy and combination therapies.
  • To discuss the clinical applications of trastuzumab and pertuzumab in conjunction with chemotherapy.
  • To explore emerging trends in anti-HER2 antibody drug development, including bispecific antibodies and immunotoxins.

Main Methods:

  • Literature review of existing studies on anti-HER2 antibody therapies.
  • Analysis of clinical data regarding trastuzumab and pertuzumab efficacy and safety.
  • Exploration of preclinical and clinical data for novel anti-HER2 antibody formats.

Main Results:

  • Trastuzumab and pertuzumab are established targeted therapies for HER2-positive cancers.
  • Combination therapies involving anti-HER2 antibodies and chemotherapy demonstrate improved outcomes.
  • Novel antibody formats show promise for enhanced efficacy and broader applicability.

Conclusions:

  • Anti-HER2 antibody therapies, including trastuzumab and pertuzumab, are crucial in treating HER2-overexpressing cancers.
  • Combination strategies and novel antibody formats represent the future direction for HER2-targeted treatment.
  • Continued research is essential to optimize anti-HER2 antibody therapies for improved patient outcomes.

More Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...